Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZTS Zoetis Inc.

盘前交易 02-10 04:25:40 EST

127.30

-0.12

-0.09%

最高128.22	最低126.34	成交量317.60万
今开127.09	昨收127.42	日振幅1.48%
总市值561.00亿	流通市值561.00亿	总股本4.41亿
成交额4.04亿	换手率0.72%	流通股本4.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":127.3,"timestamp":1770670800000,"preClose":127.42,"halted":0,"volume":3175984,"delay":0,"changeRate":-0.000941767383456322,"floatShares":440693214,"shares":440693214,"eps":5.936625,"marketStatus":"盘前交易","change":-0.12,"latestTime":"02-10 04:25:40 EST","open":127.09,"high":128.22,"low":126.34,"amount":403603856.16095996,"amplitude":0.014754,"askPrice":127.85,"askSize":100,"bidPrice":126.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":5.936625,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":127.3,"dividendRate":0.015932,"postHourTrading":{"tag":"盘后","latestPrice":127.25,"preClose":127.3,"latestTime":"19:35 EST","volume":359550,"amount":45770609.7482,"timestamp":1770683729581,"change":-0.05,"changeRate":-0.000393,"amplitude":0.000393},"volumeRatio":0.7280333411909903,"optionData":{"bulkOrders":[{"symbol":"ZTS","call":false,"expireDate":1771563600000,"strike":"110.0","timestamp":1770669532887,"price":0.5,"volume":1150,"amount":57500,"type":"-"},{"symbol":"ZTS","call":true,"expireDate":1771563600000,"strike":"135.0","timestamp":1770669532887,"price":2.35,"volume":1150,"amount":270250,"type":"+"}]},"impliedVol":0.4342,"impliedVolPercentile":0.956},"requestUrl":"/m/hq/s/ZTS/tweets","defaultTab":"tweets","newsList":[{"id":"1124112870","title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1124112870","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124112870?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:14","pubTimestamp":1770257650,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年02月12日发布最新季度财报，市场预期其营收与每股收益将温和增长，盈利质量与费用节奏成为关注焦点。从近期机构研报与观点追踪看，市场对Zoetis Inc.的看法偏多，占比较高的一方认为本季度将延续稳健增长轨迹。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"gpt_icon":0},{"id":"2606755165","title":"别只盯着黄金白银！分析师：这一商品板块正在积累动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2606755165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606755165?lang=zh_cn&edition=full","pubTime":"2026-01-28 07:27","pubTimestamp":1769556434,"startTime":"0","endTime":"0","summary":"在黄金、白银等硬商品行情持续吸引市场目光之际，软商品板块正悄悄积累动能，逐步走进“舞台”中央。化肥与基础材料板块方面，$CF工业$控股年初至今涨幅已超过18%，并录得四周连涨，为去年以来最长连胜周期。相较之下，同业$美国美盛$年内表现基本持平，凸显CF的相对强势。防御型食品板块方面，$美国达尔令国际$过去三个月累计上涨约23%，五周连涨，周线50周均线多年后首次拐头向上。","market":"us","thumbnail":"https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2fa34c06b40980242a48e390e7e61d16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398257.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADM","BG","CF","DAR","ELAN","MOO","BK4585","NTR","BK4588","ZTS","DE","MOS"],"gpt_icon":1},{"id":"1194652354","title":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=1194652354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194652354?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:20","pubTimestamp":1765866012,"startTime":"0","endTime":"0","summary":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据，到期日为2029年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","LU0107464264.USD","LU0345774391.USD","LU1941712348.USD","BK4585","LU2023251221.USD","LU0471298777.SGD","LU2111349929.HKD","BK4588","BK4007","LU0058720904.USD","IE00B19Z9505.USD","LU0079474960.USD","LU2308191902.HKD","LU1721429741.USD","LU1941712264.USD","LU2028103732.USD","LU1721429402.USD","LU2360106947.USD","LU2089284900.SGD","LU0158827781.USD","LU2271345857.HKD","BK4534","LU0385154629.USD","LU2089283258.USD","LU0289739699.SGD","LU0345774631.USD","LU0471298694.HKD","LU0158827948.USD"],"gpt_icon":0},{"id":"1199092124","title":"Zoetis获得加拿大卫生部批准，Portela™（Relfovetmab注射液）可缓解猫咪的骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1199092124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199092124?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941417,"startTime":"0","endTime":"0","summary":"Zoetis获得加拿大卫生部的批准，Portela™（Relfovetmab注射液）可用于缓解猫咪骨关节炎所致的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","ZTS","LU1721429741.USD","LU1721429402.USD","LU0158827781.USD","LU1941712348.USD","BK4585","BK4588","LU0158827948.USD","LU0471298694.HKD","LU0058720904.USD","LU2089284900.SGD","BK4007","LU0385154629.USD","IE00B19Z9505.USD","LU2089283258.USD","LU2271345857.HKD","LU2028103732.USD","LU0345774631.USD","LU0345774391.USD","BK4534","LU0079474960.USD","LU2360106947.USD","LU1941712264.USD","LU2111349929.HKD","LU0289739699.SGD","LU2023251221.USD","LU0107464264.USD","LU0471298777.SGD"],"gpt_icon":0},{"id":"1137813317","title":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1137813317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137813317?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:16","pubTimestamp":1764191777,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Lenivia®（Izenivetmab）的市场许可，以减轻犬类骨关节炎相关疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0158827781.USD","ZTS","LU2023251221.USD","LU2271345857.HKD","BK4585","BK4534","LU0107464264.USD","LU1941712348.USD","LU0079474960.USD","LU2089283258.USD","LU0158827948.USD","LU0471298694.HKD","LU0385154629.USD","LU2089284900.SGD","LU0058720904.USD","LU2028103732.USD","LU2360106947.USD","IE00B19Z9505.USD","LU2308191902.HKD","LU0345774391.USD","BK4588","LU1941712264.USD","LU0345774631.USD","BK4007","LU2111349929.HKD","LU0471298777.SGD"],"gpt_icon":0},{"id":"1187876037","title":"异动解读 | Zoetis盘前大跌9.17%，下调年度收入预期且季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1187876037","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187876037?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:40","pubTimestamp":1762260026,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.今日盘前股价大跌9.17%，引发市场关注。该公司股价在盘前交易中跌至133美元左右，较前一交易日收盘价大幅下挫。Zoetis将全年收入预测区间调整为94.0亿美元至94.8亿美元，低于此前预测的94.5亿美元至96.0亿美元。此外，Zoetis公布的第三季度业绩也未能完全达到市场预期。值得注意的是，截至上一交易日收盘，Zoetis股价已累计下跌约11%，显示出投资者对公司近期表现的持续担忧。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"gpt_icon":0},{"id":"1186621787","title":"Zoetis宣布Rob Polzer于2025年底退休，并任命Kevin Esch为2026年起全球动物健康领军企业的研发总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1186621787","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186621787?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:16","pubTimestamp":1762204575,"startTime":"0","endTime":"0","summary":"Zoetis宣布Rob Polzer将于2025年底退休，同时任命Kevin Esch为2026年起全球动物健康领域的研究与开发总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2089284900.SGD","IE00B19Z9505.USD","LU1941712264.USD","LU0158827948.USD","LU0058720904.USD","LU1941712348.USD","LU2028103732.USD","LU2111349929.HKD","BK4534","LU2089283258.USD","BK4588","LU0385154629.USD","LU2271345857.HKD","LU2360106947.USD","LU0158827781.USD","LU0345774391.USD","LU0345774631.USD","LU2308191902.HKD","LU0107464264.USD","ZTS","LU0079474960.USD","BK4007","LU2023251221.USD","LU0471298777.SGD","BK4585","LU0471298694.HKD"],"gpt_icon":0},{"id":"1156037245","title":"Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1156037245","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156037245?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:23","pubTimestamp":1761744225,"startTime":"0","endTime":"0","summary":"Zoetis Inc.：*Zoetis获欧洲委员会批准Portela®（Relfovetmab）用于缓解猫患骨关节炎相关疼痛* Zoetis Inc. - 预计Portela将在2026年在欧盟上市  ((路透社投资简报; email: reutersinvestor.briefs@thomsonreuters.com))  来源日期/时间 = 29-OCT-2025 12:30:00.16 GMT","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU0158827781.USD","LU1941712264.USD","LU2023251221.USD","LU2360106947.USD","BK4007","BK4588","LU0385154629.USD","LU2271345857.HKD","BK4534","LU1941712348.USD","LU0289739699.SGD","IE00B19Z9505.USD","BK4585","LU0107464264.USD","LU0345774391.USD","ZTS","LU0058720904.USD","LU2111349929.HKD","LU2308191902.HKD","LU2089284900.SGD","LU2028103732.USD","LU0079474960.USD","LU0158827948.USD","LU0471298777.SGD","LU0471298694.HKD","LU0345774631.USD"],"gpt_icon":0},{"id":"1143607798","title":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权以缓解猫咪与骨关节炎相关的疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1143607798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143607798?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:30","pubTimestamp":1761741033,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Portela®（Relfovetmab）的市场营销授权，以缓解猫咪与骨关节炎相关的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","LU0289739699.SGD","LU2360106947.USD","LU0345774391.USD","BK4588","LU2089283258.USD","LU1941712264.USD","LU2089284900.SGD","LU2028103732.USD","LU2023251221.USD","LU0079474960.USD","LU0345774631.USD","LU2111349929.HKD","LU1941712348.USD","LU2271345857.HKD","LU0471298777.SGD","IE00B19Z9505.USD","ZTS","BK4585","LU0158827781.USD","LU0471298694.HKD","LU0107464264.USD","LU0385154629.USD","LU0058720904.USD","BK4007","BK4534","LU0158827948.USD"],"gpt_icon":0},{"id":"1107496021","title":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1107496021","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107496021?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:01","pubTimestamp":1760526077,"startTime":"0","endTime":"0","summary":"Zoetis发布加拿大健康部门对Lenivia®（Izenivetmab注射液）用于缓解犬只骨关节炎（Oa）疼痛的批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU0079474960.USD","LU2360106947.USD","IE00B19Z9505.USD","LU1941712264.USD","LU0289739699.SGD","LU2089284900.SGD","LU2111349929.HKD","LU2308191902.HKD","LU0158827948.USD","LU0385154629.USD","BK4007","LU2271345857.HKD","BK4585","LU0158827781.USD","LU0107464264.USD","LU0345774631.USD","BK4534","LU2023251221.USD","LU0345774391.USD","LU2028103732.USD","LU0471298777.SGD","LU1941712348.USD","BK4588","LU0058720904.USD","ZTS","LU0471298694.HKD"],"gpt_icon":0},{"id":"1115730463","title":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，用于缓解犬类骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1115730463","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115730463?lang=zh_cn&edition=full","pubTime":"2025-10-11 04:16","pubTimestamp":1760127402,"startTime":"0","endTime":"0","summary":"Zoetis Inc.获得兽药产品委员会对Lenivia®(Izenivetmab)的积极意见，该药物用于缓解犬类骨关节炎疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ZTS","LU2308191902.HKD","LU0289739699.SGD","LU0107464264.USD","BK4585","LU0058720904.USD","LU0385154629.USD","LU0345774391.USD","LU0158827948.USD","LU2028103732.USD","LU1941712264.USD","LU2023251221.USD","LU0471298694.HKD","LU1941712348.USD","LU2089284900.SGD","LU0158827781.USD","LU2360106947.USD","LU2111349929.HKD","BK4534","LU0345774631.USD","LU2271345857.HKD","BK4007","LU2089283258.USD","IE00B19Z9505.USD","LU0079474960.USD","LU0471298777.SGD"],"gpt_icon":0},{"id":"1162793149","title":"Zoetis获得Dectomax®-CA1注射剂条件性批准，用于预防和治疗牛新世界螺旋蝇蛆病","url":"https://stock-news.laohu8.com/highlight/detail?id=1162793149","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162793149?lang=zh_cn&edition=full","pubTime":"2025-10-01 04:16","pubTimestamp":1759263414,"startTime":"0","endTime":"0","summary":"Zoetis获得了其Dectomax®-CA1注射剂的条件性批准，该产品专门用于预防和治疗牛的新世界螺旋蝇蛆病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0471298694.HKD","LU2308191902.HKD","LU2023251221.USD","ZTS","LU0158827781.USD","LU2360106947.USD","BK4585","LU0385154629.USD","LU2271345857.HKD","LU0345774631.USD","BK4534","LU0079474960.USD","LU1941712264.USD","LU2111349929.HKD","LU0058720904.USD","LU2028103732.USD","BK4588","BK4007","LU2089284900.SGD","LU0107464264.USD","LU0158827948.USD","LU0345774391.USD","LU0471298777.SGD","LU2089283258.USD","LU1941712348.USD","IE00B19Z9505.USD"],"gpt_icon":0},{"id":"1178037747","title":"美国卫生与公众服务部：FDA有条件批准Dectomax-CA1注射液用于预防和治疗牛类新世界螺旋蝇蛆感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1178037747","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178037747?lang=zh_cn&edition=full","pubTime":"2025-10-01 02:38","pubTimestamp":1759257500,"startTime":"0","endTime":"0","summary":"美国卫生与公众服务部宣布，美国食品药品监督管理局已有条件批准Dectomax-CA1注射液，该药物用于预防和治疗牛类新世界螺旋蝇蛆感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","LU0345774631.USD","LU0158827781.USD","LU0345774391.USD","BK4588","ZTS","LU2360106947.USD","LU0385154629.USD","LU0107464264.USD","LU0471298694.HKD","BK4007","LU0079474960.USD","LU2308191902.HKD","LU0289739699.SGD","LU2023251221.USD","LU0158827948.USD","LU2089284900.SGD","LU0058720904.USD","LU0471298777.SGD","LU1941712348.USD","BK4534","LU2111349929.HKD","LU1941712264.USD","IE00B19Z9505.USD","BK4585","LU2089283258.USD","LU2271345857.HKD"],"gpt_icon":0},{"id":"1137499971","title":"Zoetis治疗猫骨关节炎疼痛药物Portela®获得CVMP积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1137499971","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137499971?lang=zh_cn&edition=full","pubTime":"2025-09-13 00:11","pubTimestamp":1757693477,"startTime":"0","endTime":"0","summary":"Zoetis治疗猫骨关节炎疼痛药物Portela®（Relfovetmab）获得CVMP积极意见","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0471298694.HKD","LU1941712348.USD","LU2111349929.HKD","BK4534","BK4007","LU1941712264.USD","LU0058720904.USD","LU2028103732.USD","BK4588","LU0385154629.USD","LU2360106947.USD","LU0107464264.USD","LU2023251221.USD","ZTS","LU0158827948.USD","LU2089283258.USD","BK4585","LU0158827781.USD","IE00B19Z9505.USD","LU2308191902.HKD","LU0079474960.USD","LU0345774391.USD","LU0345774631.USD","LU0471298777.SGD","LU2271345857.HKD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2512046953","title":"硕腾2024财年实现净利润24.86亿美元，同比增加6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512046953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512046953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721669,"startTime":"0","endTime":"0","summary":"2月17日，硕腾公布财报，公告显示公司2024财年净利润为24.86亿美元，同比增加6.06%；其中营业收入为92.56亿美元，同比增加8.33%，每股基本收益为5.47美元。从资产负债表来看，硕腾总负债94.67亿美元，其中短期债务14.01亿美元，资产负债比为1.51，流动比率为1.76。机构评级：截至2025年2月17日，当前有15家机构对硕腾目标价做出预测，其中目标均价为214.47美元，其中最低目标价为180.00美元，最高目标价为244.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0},{"id":"2512596924","title":"动保巨头年报公布！硕腾2024年盈利约198亿元，默沙东动保营收约430亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512596924","media":"新牧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512596924?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:43","pubTimestamp":1739702626,"startTime":"0","endTime":"0","summary":"另外，近日默沙东公布2024年财报，2024年默沙东总营收641.68亿美元，同比增长7%；2024年来自动物保健部门的营收为59亿美元，同比增长4%。2024 年第四季度净利润为5.81亿美元，摊薄每股收益为1.29美元，分别较报告期增长11%和13%。2024全年净利润为25亿美元，摊薄每股收益为5.47美元，分别较报告基础增长6%和8%。2024年，默沙东总营收641.68亿美元，同比增长7%。展望2025年，默沙东预计全球销售额将在641亿美元至656亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ZTS"],"gpt_icon":0},{"id":"2511571617","title":"硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511571617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511571617?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:50","pubTimestamp":1739566218,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时50分，硕腾股票出现波动，股价急速跳水5.02%。截至发稿，该股报156.65美元/股，成交量641.473万股，换手率1.43%，振幅4.74%。最近的财报数据显示，该股实现营业收入92.56亿美元，净利润24.86亿美元，每股收益5.47美元，毛利63.96亿美元，市盈率28.67倍。硕腾股票所在的制药行业中，整体跌幅为1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089284900.SGD","LU0471298694.HKD","LU0158827948.USD","LU0345774631.USD","LU0079474960.USD","LU0058720904.USD","BK4585","BK4588","LU1941712348.USD","LU2028103732.USD","LU2360106947.USD","PTPI","LU0289739699.SGD","LU1941712264.USD","ZTS","LU2089283258.USD","LU2023251221.USD","LU2271345857.HKD","LU0385154629.USD","BK4534","BK4007","LU0158827781.USD","LU0345774391.USD","LU0471298777.SGD","LU2111349929.HKD","IE00B19Z9505.USD","LU2308191902.HKD"],"gpt_icon":0},{"id":"2511692036","title":"巴克莱：维持Zoetis(ZTS.US)评级，由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692036?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:13","pubTimestamp":1739549632,"startTime":"0","endTime":"0","summary":"巴克莱：维持Zoetis(ZTS.US)评级，由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15001348179109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZTS"],"gpt_icon":0},{"id":"2511693259","title":"硕腾发布2024年财报：宠物板块营收大增13%，中国市场迎来转折","url":"https://stock-news.laohu8.com/highlight/detail?id=2511693259","media":"宠物行业白皮书","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511693259?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:30","pubTimestamp":1739529054,"startTime":"0","endTime":"0","summary":"白皮书团队讯，2月13日，硕腾正式发布了其2024年财报：全年营收93亿美元，同比增长8%，净利润25亿美元；第四季度营收23亿美元，同比增长5%，净利润5.81亿美元。这一变化也表现在了业绩上，实际上，自2023Q1季度开始，硕腾在国内市场的营收已经连续7个季度同比下滑了。但受前三季度业绩拖累，2024年全年，硕腾中国市场累计营收2.70亿美元，同比下降约16%。附：硕腾2024年业绩演示报告End《2025年中国宠物行业白皮书》正式发布行业资料包","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YINN","ZTS"],"gpt_icon":0},{"id":"2511694829","title":"硕腾2024年财报：犬猫业务营收近60亿美元，增长13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694829","media":"宠业家","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694829?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:30","pubTimestamp":1739525444,"startTime":"0","endTime":"0","summary":"2024全年净利润为25亿美元，摊薄每股收益为5.47美元，分别较报告基础增长6%和8%。其中，硕腾2024年第四季度营收为23亿美元，较2023年第四季度增长5%。2024 年第四季度净利润为5.81亿美元，摊薄每股收益为1.29美元，分别较报告期增长11%和13%。第四季度伴侣动物产品的营收为15.70亿美元，同比增长8%，犬猫业务线营收14.77亿美元，同比增长9%。分区域来看，硕腾美国市场2024年营收为50.74亿美元，同比增速高达11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231351a2460af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231351a2460af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":0.0189},{"period":"1month","weight":0.001},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.1649},{"period":"1year","weight":-0.2574},{"period":"ytd","weight":0.0118}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.014971},{"month":2,"riseRate":0.615385,"avgChangeRate":0.015688},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.013564},{"month":4,"riseRate":0.538462,"avgChangeRate":0.015522},{"month":5,"riseRate":0.692308,"avgChangeRate":0.026998},{"month":6,"riseRate":0.692308,"avgChangeRate":0.013528},{"month":7,"riseRate":0.846154,"avgChangeRate":0.031992},{"month":8,"riseRate":0.769231,"avgChangeRate":0.012395},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.008448},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}